Skip to main content
. 2016 Aug 19;7(38):62240–62254. doi: 10.18632/oncotarget.11404

Figure 7. Inhibition of prostate tumor xenografts by salinomycin.

Figure 7

A. Growth curves for LNCaP-II xenografts in nude male mice treated with vehicle or salinomycin. Mice received i.p. injections of salinomycin or vehicle every 3rd day; n=5. * p ≤ 0.04. B, C. CYP17A1 (B) and phospho-RPS (C) levels in LNCaP-II xenografts, showing data from two individual mice for control and experimental groups. D. Growth rates of C4-2 tumor xenografts. Salinomycin (or vehicle) was delivered via oral gavage every 2nd day. ** p ≤ 0.01; #p ≤ 0.05.